OEM by QIAGEN advancing with Asian molecular diagnostic companies

Partner Content |  Opinion | 0 Comment | 29 Oct, 2021

How has the pandemic affected the OEM business? COVID-19 was an unprecedented challenge for the life science industry. ...Read more

"The future of patient care could potentially be on a completely remote basis"

Partner Content |  Opinion | 1 Comment | 07 Oct, 2021

BioSpectrum Asia spoke to Benjamin Low, Vice-President, Asia Pacific, Milestone Systems, on how Singapore and APAC can m...Read more

“We see great potential for mRNA technology to address a broader range of diseases”

Partner Content |  Opinion | 0 Comment | 04 Aug, 2021

What big plans are in store to enhance the global production of mRNA vaccines in the future? As part of our long-term g...Read more

“Keep investing in expanding manufacturing capacity is our commitment to customers”

Partner Content |  Opinion | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 03 Aug, 2021

What are the new initiatives being planned for the APAC market? Are there any launches or announcements in the pipeline ...Read more

"We see growing interest of healthcare testing labs, Pharmaceutical QC and R&D labs in implementing next-gen lab automation solutions"

Partner Content |  Opinion | 2 Comment | 01 Jul, 2021

Can you tell us about the major product releases of STARLIMS since 2020?    It's the result of regular colla...Read more

For the automation portfolio, we see a strong and growing demand for application-related solutions : Dr Peter Fruhstorfer

Partner Content |  Opinion | By Ankit Kankar | ankit.kankar@mmactiv.com | 1 Comment | 01 Jun, 2021

In the fiscal year 2020, Eppendorf AG succeeded in posting record revenue of €967.2 million as compared to ...Read more

"We've unveiled many novel analytical workflows which can be used in developing vaccines"

Partner Content |  Opinion | 0 Comment | 10 May, 2021

With a focus on extending the company’s leadership in quantitative LC-MS, and oversee the launch of innovative tec...Read more

We consider the APA and China markets as highly attractive, fast-growing and very innovative : Eva van Pelt

Partner Content |  Influencers | By Ankit Kankar | ankit.kankar@mmactiv.com | 2 Comment | 28 Feb, 2021

  1.What have been your key contributions within the organization towards fighting covid-19? The current challeng...Read more

“We are planning to launch a new bioprocess controller in Q1 2021”

Partner Content |  Opinion | 0 Comment | 04 Jan, 2021

Their applications are diverse, and the products can be found in pharmaceutical, chemical, and nutrition industries. Wit...Read more